Is genome-guided cancer treatment hyped?
For people with advanced cancer who are running out of options, many cancer centers now offer this hope: Have your tumor9s genome sequenced, and doctors will match you with a drug that targets its weak spot. But this booming area of cancer treatment has critics, who say its promise has been oversold. Last week, two prominent voices in the field faced off in a sometimes-tense debate on what9s often called precision oncology at the annual meeting of the American Association for Cancer Research in Chicago, Illinois. Their dispute threw a splash of cold water on a meeting packed with sessions on genome-based cancer treatments.